INFLUENCE OF NICARDIPINE, NIMODIPINE AND FLUNARIZINE ON THE ANTICONVULSANT EFFICACY OF ANTIEPILEPTICS AGAINST PENTYLENETETRAZOL IN MICE

Citation
M. Gasior et al., INFLUENCE OF NICARDIPINE, NIMODIPINE AND FLUNARIZINE ON THE ANTICONVULSANT EFFICACY OF ANTIEPILEPTICS AGAINST PENTYLENETETRAZOL IN MICE, Journal of neural transmission, 103(7), 1996, pp. 819-831
Citations number
42
Categorie Soggetti
Clinical Neurology",Neurosciences
ISSN journal
03009564
Volume
103
Issue
7
Year of publication
1996
Pages
819 - 831
Database
ISI
SICI code
0300-9564(1996)103:7<819:IONNAF>2.0.ZU;2-5
Abstract
Among three calcium channel inhibitors, only nicardipine (10-40 mg/kg) significantly inhibited clonic seizures induced by pentylenetetrazol administered at its CD97 (convulsive dose 97%) of 81 mg/kg, subcutaneo usly. Nimodipine and flunarizine (both up to 80 mg/kg) did not suppres s pentylenetetrazol-induced clonic seizures per se. Co-administration of nicardipine (5 mg/kg) resulted in a significant enhancement of the protective potency of either ethosuximide (50 mg/kg) or valproate (100 mg/kg) against clonic seizures in this test. Similar effects were not ed in case of combined treatment of nimodipine (20-40 mg/kg) with thes e antiepileptics. On the contrary: flunarizine (up to 20 mg/kg) did no t modify the anticonvulsive action of these antiepileptic drugs. Moreo ver, none of the studied calcium channel inhibitors influenced the pro tective activity of clonazepam (0.01 mg/kg). The antiepileptic drugs, administered alone in above doses, were ineffective against pentylenet etrazol-induced clonic convulsions. In case of ethosuximide and valpro ate, the motor performance in the chimney test was worsened by co-admi nistration of nimodipine (40 mg/kg). We found no pharmacokinetic inter actions (at least in relation to the plasma levels of ethosuximide and valproate) that could explain the observed results. Thus. we conclude that a combination of some calcium channel inhibitors and antiepilept ic drugs may provide more efficient protection against experimental se izures which may bear a potential clinical significance.